In patients with NSCLC, the investigators sought to determine differences in T cells between patients with high levels of plasma IL-6 (> median of 6.41 pg/ml) compared to low levels (< 6.41 pg/ml), as high levels of IL-6 are associated with poor prognosis in these patients [43]. This evidence concerns the gene IL6 and non-small cell lung carcinoma.